Human wounds take almost three times as long to heal as those of other primates, which may come down to our lack of fur ...

In a phase 3 trial, 81% of wounds treated with autologous cell sheet-based gene therapy showed ≥ 50% healing at 6 months, ...

A 47-year-old man here had his left lower leg amputated after developing a severe bacterial infection days following ...

A 5-year-old girl from Kozhikode undergoing treatment for rabies died due to the virus despite getting preventive vaccination ...

Patients with the debilitating dermatologic condition are born with COL7A1 mutations in both gene copies, affecting the ...

Riverside Health and Rehab and White Oak Manor Charleston are expected to be sued for wrongful death, according to notice ...

Cleveland-based Abeona Therapeutics Inc. (Nasdaq: ABEO) announced Tuesday, April 29, that it has received U.S. Food and Drug ...

The condition, recessive dystrophic epidermolysis bullosa, causes chronic wounds and has an 84% mortality rate by age 40.

Prademagene zamikeracel (Zevaskyn) is the first and only cell-based gene therapy for wound treatment in patients with ...

Can your pet catch COVID-19 or the common cold from you? What can you expect the treatment to be if both you and your pet ...

The FDA has approved Zevaskyn for the treatment of recessive dystrophic epidermolysis bullosa, the company announced in a ...

The widow of an 81-year-old man who died in Jersey’s General Hospital six years ago after developing one of the worst pressure sores local nurses had ever seen has today broken her silence – as new ...